SCHEMBL22211342

SCHEMBL22211342

COC(=O)C1(Cc2ccc(CCl)cc2)CCCC1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.44
TACR3 P29371 1/20 0.44
CYP2C19 P33261 5/20 0.36
GPR119 Q8TDV5 1/20 0.35
MAPT P10636 4/20 0.34
CYP3A4 P08684 3/20 0.34
TSHR P16473 3/20 0.34
GAA P10253 2/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
MGAM O43451 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP2C9 P11712 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2039023 0.89 TACR1 (0.44) TACR1TACR3CYP2C19MAPTPOLB
SCHEMBL8830812 0.88 TACR1 (0.45) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL9168218 0.86 TACR1 (0.44) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL4809720 0.86 TACR1 (0.55) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL9363274 0.85 TACR1 (0.44) TACR1TACR3MAPTPOLBNPC1
SCHEMBL26679406 0.85 TACR3 (0.57) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL8830633 0.84 TACR1 (0.51) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL8830792 0.84 TACR1 (0.43) TACR1TACR3GPR119MAPTRECQL
SCHEMBL22211320 0.83 TACR1 (0.42) TACR1TACR3CYP2C19GPR119MAPT
SCHEMBL8830648 0.83 GPR119 (0.45) TACR1TACR3CYP2C19GPR119CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210078941-A1 Method For Preparing Substituted Phenylacetic Acid Derivative JIANGSU RUIKE MEDICAL SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2021-03-18 US disclosed
EP-3680227-A1 METHOD FOR PREPARING SUBSTITUTED PHENYLACETIC ACID DERIVATIVE Jiangsu Ruike Medical Science And Technology Co., Ltd. (CN) 2020-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210078941-A1 Method For Preparing Substituted Phenylacetic Acid Derivative ALOX5, LOXL4, CYP3A5 TACR1 919/4885TACR3 1262/4885CYP2C19 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.